The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
Open accessPublished version of a preprint
Abstract
Significance: The hypoxic microenvironment in solid tumors is known to reduce the efficacy of anticancer treatments in many cancer types, including breast cancer. This study shows hypoxia induces an amino acid transporter, SNAT2, which then causes resistance to antihormone therapy. We show major interplay between genes induced by estrogen receptor and hypoxia. Hypoxia-inducible factor 1α compensates for the loss of expression of estrogen receptor-α (ERα) for maintaining SNAT2 expression under hypoxia or endocrine therapies. SNAT2 overexpression produces complete resistance to antiestrogen therapy in vivo and is induced in tamoxifen resistance, and its expression is associated with poor survival in breast cancer and resistance to endocrine therapy in ERα + luminal B patients. Our findings thus have revealed a previously unidentified mechanism for antiestrogen resistance driven by tumor metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Fig. 6. SNAT2 expression is related to poor outcomes in endocrine-treated breast cancer patients. (A) Xenograft growth curves of MCF7 parental and SNAT2-o clones ± bevacizumab (BEV) or ± fulvestrant (FULV) treatment. CTL, control. ***P < 0.001, **P < 0.01, *P < 0.05; linear regression followed by Student’s t test (n = 5). (B) Kaplan–Meier plot for patients from the TGCA breast cancer invasive cohort (ALL and ER+ cohorts) stratified according to the expression of SNAT2 mRNA expression (T1, lower tertile; T2, middle tertile; T3, upper tertile). Overall survival (OS) was evaluated. The graph shows that high tumor SNAT2 levels are associated with increased patient mortality. Subanalysis based on tertile expression showed that the higher SNAT2 mRNA expression (upper tertile) cohort has a lower survival compared with the lower tertile cohort (T3 vs. T1). HR, hazard ratio. (C) Kaplan–Meier plots for luminal A and B ER+ breast cancer patients (Left) and for same subgroups that received endocrine [aromatase inhibitor (AI) or tamoxifen (TAM), Center] or tamoxifen only (Right). Patients were stratified according to the expression of SNAT2 mRNA [above (red) versus below (black) third quartile]. Recurrence-free survival was evaluated.](https://figures.cochat.ai/paper-figures/4f913bb6ca604c7dad67dd935041e2a5/hypoxia-induced-switch-in-snat2-slc38a2-regulation-generates-endocrine-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition to promoting lipid synthesis, the HIFs also directly promote lipid uptake and lipid droplet formation, while decreasing β-oxidation (see section on mitochondria), which increases the cellular fatty acid pool that can be utilized as an energy source or channeled to other uses to facilitate tumor proliferation.”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [57]
Experimental — accuracy not yet measuredIn the citing paper
“Hypoxic conditions promote the uptake of glutamine by increasing the levels of glutamine transporters such as SLC1A5, the SLC1A5 variant, and SLC38A216,65”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Hypoxia is a key microenvironmental difference between tumor and normal tissues and is related to poor clinical prognosis and resistance to therapies in many solid tumors, including breast cancer (6).”
Self-citationHypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
Harbeck, N., & Gnant, M. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31891-8 · Cited by 2,280
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Cited by
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
Cellular Adaptation to Hypoxia through Hypoxia Inducible Factors and beyond
Lee, P., Chandel, N. S., & Simon, M. C. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0227-y · Cited by 1,272
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Overcoming Endocrine Resistance in Breast Cancer
Hanker, A. B., Sudhan, D. R., & Arteaga, C. L. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.009 · Cited by 927
The effect of HIF on metabolism and immunity
Taylor, C. T., & Scholz, C. C. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00587-8 · Cited by 517
Metadata
- Authors
- Morotti, M., Bridges, E., Valli, A., Choudhry, H., Sheldon, H., Wigfield, S., Gray, N., Zois, C. E., Grimm, F., Jones, D., Teoh, E. J., Cheng, W.-C., Lord, S., Anastasiou, D., Haider, S., McIntyre, A., Goberdhan, D. C. I., Buffa, F., & Harris, A. L.
- Affiliations
- Cancer Research UK (GB)
- King Abdulaziz University (SA)
- John Radcliffe Hospital (GB)
- The Francis Crick Institute (GB)
- University of Oxford (GB)
- Institute of Cancer Research (GB)
- University of Nottingham (GB)
- University of California San Diego (US)
- Corresponding author
- Morotti, Matteo
- Harris, Adrian L.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2019-05-31
- Volume
- 116
- Issue
- 25
- Pages
- 12452-12461
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6589752
- OpenAlex
- W2885171918
- Cited by
- 131
- References
- 83
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 14 · 2022: 17 · 2021: 27 · 2020: 20 · 2019: 2
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by-nc-nd)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Archivio istituzionale della Ricerca - Bocconi (submittedVersion)
- The Francis Crick Institute
- Funders
- Breast Cancer Research Foundation (BCRF-17-064)
- Fondazione Umberto Veronesi (2018)
- Cancer Research UK (ANR00163)
- Oxford NIHR Biomedical Research Centre (2018)
- Oxfordshire Community Foundation (8297)
- Friends of Kennington Cancer Fund (2018)
- RCUK | Medical Research Council (MC_UP_1202/1)
- Francis Crick Institute (FC001033)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- SNAT2, SLC38A2, breast cancer, hypoxia, endocrine therapy resistance, estrogen receptor alpha, HIF-1α, glutamine transport, fulvestrant, antiestrogen therapy, anti-VEGF therapy, tumor hypoxia, drug resistance
- MeSH terms
- Animals, Breast Neoplasms, Female, Humans, Cell Hypoxia, Antineoplastic Agents, Hormonal, Drug Resistance, Neoplasm, Estrogen Receptor Modulators, Amino Acid Transport System A, Cell Line, Tumor, Estrogen Receptor alpha, Mice, Tumor Microenvironment, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. https://app.cochat.ai/papers/10.1073/pnas.1818521116
- The paper
- Morotti, M., Bridges, E., Valli, A., Choudhry, H., Sheldon, H., Wigfield, S., Gray, N., Zois, C. E., Grimm, F., Jones, D., Teoh, E. J., Cheng, W.-C., Lord, S., Anastasiou, D., Haider, S., McIntyre, A., Goberdhan, D. C. I., Buffa, F., & Harris, A. L. (2019). Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1818521116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.